GSK stock: 5.6% bounce in the confirmation week
GSK stock rebounds 5.6% as the confirmation week stays open
Our view last week
GSK breaks below its trigger level and sheds 7.3% in a week, its heaviest drop in months. The picture flips: last week GSK stock was still inside a buy signal, and now a fresh sell signal kicks in, ranking third of 47 in our European-UK ranking. Signal strength is already at 94 out of 100 - the model reads it as a decline under way at lower lows, with the push still intact. The stock still sits above its 200-week average.
This week's summary
GSK stock bounces 5.6% this week, but the technical picture doesn't back up the strength of the move: two conflicting rejection candles and contracting volumes ride along with it. The Sell signal is still in its confirmation week, with strength down to 38 out of 100 - a decline holding its direction but with no fresh push. GSK stock still sits above its 200-week average, with wide running room before the next historical resistance.
IQS Phase
62
ordinary
Signal Strength
38
decline losing steam
Sizing
REDUCED
Ranking
#13 / 46
EU-UK stocks sell signals
Trade P&L %
-5.56%
from signal to date, no stop loss
Rank position
ranks 13th among the 46 sell signals for European-UK stocks in our ranking, with a signal strength of 38 out of 100.
Sector context
SectorEuropean
Benchmark ETFEXV4
Sector regimein strong phase
Performanceweekly +4.34% · monthly +2.68%
GSK belongs to the european sector (reference ETF EXV4). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content